Agency Forms Undergoing Paperwork Reduction Act Review, 22072-22074 [2018-10064]
Download as PDF
<![CDATA[
22072
Federal Register / Vol. 83, No. 92 / Friday, May 11, 2018 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Type of respondents
Form name
Household ...............................................................................
Male 15–49 years of age ........................................................
Household ...............................................................................
member ...................................................................................
Household ...............................................................................
Individual 15–49 years of age ................................................
Male Interview ........................
2,250
1
1
Screener Verification ..............
1,500
1
2/60
Main Verification .....................
500
1
5/60
Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–10065 Filed 5–10–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
of the Advisory Board on Radiation and
Worker Health (ABRWH). This meeting
is open to the public, but without a
public comment period. The public is
welcome to submit written comments in
advance of the meeting, to the contact
person below. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. The public is also welcome to
listen to the meeting by joining the
teleconference at the USA toll-free, dialin number at 1–866–659–0537; the pass
code is 9933701. The conference line
has 150 ports for callers.
DATES: The meeting will be held on June
26, 2018, 11:00 a.m. to 1:00 p.m. EDT.
ADDRESSES: Audio Conference Call via
FTS Conferencing. The USA toll-free
dial-in number is 1–866–659–0537; the
pass code is 9933701.
FOR FURTHER INFORMATION CONTACT:
Theodore Katz, MPA, Designated
Federal Officer, NIOSH, CDC, 1600
Clifton Road, Mailstop E–20, Atlanta,
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:21 May 10, 2018
Jkt 244001
Georgia 30333, Telephone (513) 533–
6800, Toll Free 1 (800) CDC–INFO,
Email ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC). In
December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to the CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
rechartered under Executive Order
13811 on February 12, 2018, and will
terminate on September 30, 2019.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
radiation doses may have endangered
the health of members of this class.
Matters to be Considered: The agenda
will include discussions on: Work
Group and Subcommittee Reports;
Update on the Status of SEC Petitions;
Plans for the August 2018 Advisory
Board Meeting; and Advisory Board
Correspondence. Agenda items are
subject to change as priorities dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2018–10110 Filed 5–10–18; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–18–18KG]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Information
Collection for ‘‘The EDN Tuberculosis
Follow-Up Worksheet for NewlyArrived Persons with Overseas
Tuberculosis Classifications’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on January 31, 2018 to obtain
comments from the public and affected
agencies. CDC received nine comments
E:\FR\FM\11MYN1.SGM
11MYN1
Federal Register / Vol. 83, No. 92 / Friday, May 11, 2018 / Notices
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
sradovich on DSK3GMQ082PROD with NOTICES
Proposed Project
Information Collection for ‘‘The EDN
Tuberculosis Follow-Up Worksheet for
Newly-Arrived Persons with Overseas
Tuberculosis Classifications’’—Existing
Collection in Use without an OMB
Control Number—National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The Division of Global Migration and
Quarantine (DGMQ) collaborated
closely with several partners, including
the U.S. tuberculosis coordinators in
U.S. health departments, National
Tuberculosis Controllers Association
(NTCA), EDN System workgroup, and
the CDC Division of Tuberculosis
Elimination (DTBE) to develop the
proposed worksheet to capture followup medical examination information
after a person with tuberculosis
classification has arrived in the U.S. The
overseas medical examination
determines whether the applicant has
an inadmissible condition of public
health significance (a Class A condition)
or has a health-related condition that is
admissible but that might require
extensive medical treatment or followup (a Class B condition), such as treated
tuberculosis. Applicants with Class A
(inadmissible) conditions can only enter
the United States if they are granted a
waiver. Applicants who have Class A
conditions include those who (1) have
a communicable disease of public
health significance, (2) do not have
documentation of having received
vaccinations against vaccinepreventable diseases, (3) have a physical
or mental disorder with associated
harmful behavior, or (4) abuse or are
addicted to drugs (42 U.S.C. 252, 8
U.S.C. 1182, and 8 U.S.C. 1222 provide
for the physical and mental examination
of applicants in accordance with
regulations prescribed by the HHS
Secretary.)1 CDC highly recommends
that persons with overseas class A or B
tuberculosis receive domestic follow-up
medical examination information to
prevent new transmission of
tuberculosis. This is the primary
rationale for collecting domestic
tuberculosis follow-up information.
The U.S. foreign-born population
continuously had the highest incidence
of tuberculosis compared to the U.S.
non-foreign born population. CDC
strongly recommends U.S.-bound
immigrants and refugees with class A or
B tuberculosis to receive follow-up
examinations for tuberculosis in the
U.S. The purpose of this data collection
is to methodically gather tuberculosis
follow-up outcome data to monitor and
track U.S.-bound persons with overseas
class A and B tuberculosis to assist in
the national effort to prevent new
transmission of tuberculosis. To
accurately determine recent U.S.
arrivals receiving domestic follow-up
medical examination information, U.S.
health departments will provide
domestic follow-up outcome
information to CDC. Without this data,
DGMQ will not have a method of
tracking and monitoring newly-arrived
persons with overseas class A or B
tuberculosis. DGMQ will use
information reported on the
Tuberculosis Follow-Up Worksheet to
ensure that tuberculosis programs are
effectively tracking newly-arrived
persons and coordinating follow-up
medical examination information with
local clinicians.
Several indicators will be calculated
to measure domestic tuberculosis
program performance, including the
percentage of aliens with class B
tuberculosis with complete US medical
examinations. This program
performance monitoring activity will be
ongoing throughout the year. State and
local health departments will
voluntarily report evaluation outcome
findings on a continuous basis once
evaluation results for an individual
becomes available.
Data collected by DGMQ will be used
to help evaluate the efficacy and
efficiency of overseas tuberculosis
diagnosis, treatment, and prevention
activities along with panel physician
performance. Currently, DGMQ does not
have an effective method of determining
the accuracy of chest x-rays read
overseas and the aptness of overseas
treatment for tuberculosis. This data
will provide DGMQ with a method of
evaluating panel physician performance
and overseas treatment and prevention
activities. The proposed Worksheet
contains sections that allow U.S.
physicians to review overseas chest xrays and treatment and indicate any
concerns or errors. A negative
consequence of not collecting this
information is that DGMQ will not be
able to quickly analyze data to
determine which panel physicians have
the most inaccuracies. Plans for formal
evaluations of US panel physicians are
contingent upon the approval of the
Tuberculosis Follow-Up Worksheet.
If technical instructions for
tuberculosis diagnosis and treatment are
followed properly overseas, persons
with overseas classification B
tuberculosis should not have
tuberculosis disease during their US
follow-up examinations. The form will
help DGMQ understand what factors
may contribute to a domestic diagnosis
of tuberculosis. The Worksheet contains
a section that collects patient diagnoses
and treatment recommendations.
Without this information, DGMQ staff
will not be able to accurately identify
and resolve factors that contribute to
tuberculosis disease. This form of
monitoring is ongoing and will occur
with every instance an alien is
diagnosed with tuberculosis disease
during follow-up examinations.
There are no costs to the respondents
other than their time. The total
estimated annual burden is 13,200
hours.
1
VerDate Sep<11>2014
19:21 May 10, 2018
Jkt 244001
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
22073
E:\FR\FM\11MYN1.SGM
11MYN1
22074
Federal Register / Vol. 83, No. 92 / Friday, May 11, 2018 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
EDN data entry staff at state and local health
departments.
The EDN Tuberculosis Follow-up Worksheet
for Newly-Arrived Persons With Overseas
Tuberculosis Classifications.
Jeffrey Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–10064 Filed 5–10–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–18–0666; Docket No. CDC–2018–
0042]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled National Healthcare Safety
Network (NHSN). NHSN is a public
health surveillance system that collects,
analyzes, reports, and makes available
data for monitoring, measuring, and
responding to healthcare associated
infections (HAIs), antimicrobial use and
resistance, blood transfusion safety
events, and the extent to which
healthcare facilities adhere to infection
prevention practices and antimicrobial
stewardship.
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
CDC must receive written
comments on or before July 10, 2018.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2018–
0042 by any of the following methods:
DATES:
VerDate Sep<11>2014
19:21 May 10, 2018
Jkt 244001
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Leroy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
550
48
Average
burden per
response
(in hours)
30/60
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
National Healthcare Safety Network
(NHSN)—Revision—National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
NHSN is a public health surveillance
system that collects, analyzes, reports,
and makes available data for
monitoring, measuring, and responding
to healthcare associated infections
(HAIs), antimicrobial use and resistance,
blood transfusion safety events, and the
extent to which healthcare facilities
adhere to infection prevention practices
and antimicrobial stewardship. The data
collected will be used to inform and
detect changes in the epidemiology of
adverse events resulting from new and
current medical therapies and changing
risks. NHSN is comprised of six
components: Patient Safety, Healthcare
Personnel Safety, Biovigilance, LongTerm Care Facility, Outpatient
Procedure, and Dialysis.
Changes were made to 33 data
collection facility surveys with this new
ICR. CDC revised three annual facility
surveys for the Patient Safety
component for Hospitals, Long-Term
Acute Care Facilities, and Inpatient
Rehabilitation Facilities. CDC’s
revisions clarify the reporting
requirements for the data collected on
fungal testing, facility locations, and
laboratory testing locations.
Additionally, corresponding response
E:\FR\FM\11MYN1.SGM
11MYN1
]]>Agencies
[Federal Register Volume 83, Number 92 (Friday, May 11, 2018)]
[Notices]
[Pages 22072-22074]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-10064]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-18-18KG]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Information Collection for ``The EDN
Tuberculosis Follow-Up Worksheet for Newly-Arrived Persons with
Overseas Tuberculosis Classifications'' to the Office of Management and
Budget (OMB) for review and approval. CDC previously published a
``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on January 31, 2018 to obtain comments from
the public and affected agencies. CDC received nine comments
[[Page 22073]]
related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Information Collection for ``The EDN Tuberculosis Follow-Up
Worksheet for Newly-Arrived Persons with Overseas Tuberculosis
Classifications''--Existing Collection in Use without an OMB Control
Number--National Center for Emerging and Zoonotic Infectious Diseases
(NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Division of Global Migration and Quarantine (DGMQ) collaborated
closely with several partners, including the U.S. tuberculosis
coordinators in U.S. health departments, National Tuberculosis
Controllers Association (NTCA), EDN System workgroup, and the CDC
Division of Tuberculosis Elimination (DTBE) to develop the proposed
worksheet to capture follow-up medical examination information after a
person with tuberculosis classification has arrived in the U.S. The
overseas medical examination determines whether the applicant has an
inadmissible condition of public health significance (a Class A
condition) or has a health-related condition that is admissible but
that might require extensive medical treatment or follow-up (a Class B
condition), such as treated tuberculosis. Applicants with Class A
(inadmissible) conditions can only enter the United States if they are
granted a waiver. Applicants who have Class A conditions include those
who (1) have a communicable disease of public health significance, (2)
do not have documentation of having received vaccinations against
vaccine-preventable diseases, (3) have a physical or mental disorder
with associated harmful behavior, or (4) abuse or are addicted to drugs
(42 U.S.C. 252, 8 U.S.C. 1182, and 8 U.S.C. 1222 provide for the
physical and mental examination of applicants in accordance with
regulations prescribed by the HHS Secretary.)\1\ CDC highly recommends
that persons with overseas class A or B tuberculosis receive domestic
follow-up medical examination information to prevent new transmission
of tuberculosis. This is the primary rationale for collecting domestic
tuberculosis follow-up information.
---------------------------------------------------------------------------
1
---------------------------------------------------------------------------
The U.S. foreign-born population continuously had the highest
incidence of tuberculosis compared to the U.S. non-foreign born
population. CDC strongly recommends U.S.-bound immigrants and refugees
with class A or B tuberculosis to receive follow-up examinations for
tuberculosis in the U.S. The purpose of this data collection is to
methodically gather tuberculosis follow-up outcome data to monitor and
track U.S.-bound persons with overseas class A and B tuberculosis to
assist in the national effort to prevent new transmission of
tuberculosis. To accurately determine recent U.S. arrivals receiving
domestic follow-up medical examination information, U.S. health
departments will provide domestic follow-up outcome information to CDC.
Without this data, DGMQ will not have a method of tracking and
monitoring newly-arrived persons with overseas class A or B
tuberculosis. DGMQ will use information reported on the Tuberculosis
Follow-Up Worksheet to ensure that tuberculosis programs are
effectively tracking newly-arrived persons and coordinating follow-up
medical examination information with local clinicians.
Several indicators will be calculated to measure domestic
tuberculosis program performance, including the percentage of aliens
with class B tuberculosis with complete US medical examinations. This
program performance monitoring activity will be ongoing throughout the
year. State and local health departments will voluntarily report
evaluation outcome findings on a continuous basis once evaluation
results for an individual becomes available.
Data collected by DGMQ will be used to help evaluate the efficacy
and efficiency of overseas tuberculosis diagnosis, treatment, and
prevention activities along with panel physician performance.
Currently, DGMQ does not have an effective method of determining the
accuracy of chest x-rays read overseas and the aptness of overseas
treatment for tuberculosis. This data will provide DGMQ with a method
of evaluating panel physician performance and overseas treatment and
prevention activities. The proposed Worksheet contains sections that
allow U.S. physicians to review overseas chest x-rays and treatment and
indicate any concerns or errors. A negative consequence of not
collecting this information is that DGMQ will not be able to quickly
analyze data to determine which panel physicians have the most
inaccuracies. Plans for formal evaluations of US panel physicians are
contingent upon the approval of the Tuberculosis Follow-Up Worksheet.
If technical instructions for tuberculosis diagnosis and treatment
are followed properly overseas, persons with overseas classification B
tuberculosis should not have tuberculosis disease during their US
follow-up examinations. The form will help DGMQ understand what factors
may contribute to a domestic diagnosis of tuberculosis. The Worksheet
contains a section that collects patient diagnoses and treatment
recommendations. Without this information, DGMQ staff will not be able
to accurately identify and resolve factors that contribute to
tuberculosis disease. This form of monitoring is ongoing and will occur
with every instance an alien is diagnosed with tuberculosis disease
during follow-up examinations.
There are no costs to the respondents other than their time. The
total estimated annual burden is 13,200 hours.
[[Page 22074]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
EDN data entry staff at state and The EDN Tuberculosis Follow- 550 48 30/60
local health departments. up Worksheet for Newly-
Arrived Persons With
Overseas Tuberculosis
Classifications.
----------------------------------------------------------------------------------------------------------------
Jeffrey Zirger,
Acting Chief, Information Collection Review Office, Office of
Scientific Integrity, Office of the Associate Director for Science,
Office of the Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-10064 Filed 5-10-18; 8:45 am]
BILLING CODE 4163-18-P
